Company: RPTX
Filing Date: 2025-11-17
Form Type: DEFA14A
Source: 0001193125-25-284040
Chunk: 11

Company: Repare Therapeutics Inc.
Filing Date: 2025-11-17
Form: DEFA14A
Chunk 11
---
 of any subsidiary) representing 20% or more of the 
 consolidated assets of the Company and its Subsidiary;                                                                                                                                                                                                   |

| (iii) | an amalgamation, arrangement, share exchange, merger, business combination, consolidation, recapitalization or 
 other similar transaction involving the Company or its Subsidiary;                                             |

| (iv) | any take-over bid, tender offer, exchange offer, treasury issuance,                                                                                                                                           
 re-capitalization or other similar transaction involving the Company that, if consummated, would result in a person or group of persons acting jointly or in concert acquiring beneficial ownership of 20% or 
 more of any class of equity or voting securities of the Company and assuming the conversion of any convertible securities held by the person or group of persons acting jointly or in concert; or             |

| (v) | any other announcement, transaction or series of transactions involving the Company or its Subsidiary that 
 would have a similar effect as the foregoing;                                                              |

- 2 -

| (d) | “affiliate” has the meaning ascribed thereto in National Instrument 45-106 – Prospectus Exemptions; |

| (e) | “Agreement” means this arrangement agreement among Parent, the Purchaser, XRC and the                                                            
 Company (including the Schedules attached hereto) as it may be amended, modified or supplemented from time to time in accordance with its terms; |

| (f) | “Alternate Resolution” means the special resolution approving the orderly liquidation and                                            
 dissolution of the Company if the Contemplated Transactions are not consummated by the Outside Date to be considered at the Meeting; |

| (g) | “AMF” means the Autorité des marchés financiers (Québec); |

| (h) | “AML Laws” has the meaning set out in paragraph 34(d) of Schedule E to this Agreement; |

| (i) | “Anti-Corruption Laws” has the meaning set out in paragraph 34(a) of Schedule E to this 
 Agreement;                                                                              |

| (j) | “Arrangement” means an arrangement under Chapter XVI – Division II of the QBCA in                                                                                                                                                                        
 accordance with the terms and subject to the conditions set out in the Plan of Arrangement, subject to any amendments or variations to the Plan of Arrangement made in accordance with the terms of this Agreement or the Plan of Arrangement or made at 
 the direction of the Court in the Final Order with the prior